Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.

Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, Madore J, Lepletier A, Aguilera AR, Sundarrajan A, Jacoberger-Foissac C, Wong C, Dela Cruz T, Welch M, Lerner AG, Spatola BN, Soros VB, Corbin J, Anderson AC, Effern M, Hölzel M, Robson SC, Johnston RL, Waddell N, Smith C, Bald T, Geetha N, Beers C, Teng MWL, Smyth MJ.

Cancer Discov. 2019 Dec;9(12):1754-1773. doi: 10.1158/2159-8290.CD-19-0541. Epub 2019 Nov 7.

PMID:
31699796
2.

Nuclear and cytoplasmic WDR-23 isoforms mediate differential effects on GEN-1 and SKN-1 substrates.

Spatola BN, Lo JY, Wang B, Curran SP.

Sci Rep. 2019 Aug 13;9(1):11783. doi: 10.1038/s41598-019-48286-y.

3.

WDR23 regulates NRF2 independently of KEAP1.

Lo JY, Spatola BN, Curran SP.

PLoS Genet. 2017 Apr 28;13(4):e1006762. doi: 10.1371/journal.pgen.1006762. eCollection 2017 Apr.

4.

Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease.

Spatola BN, Kaukinen K, Collin P, Mäki M, Kagnoff MF, Daugherty PS.

Aliment Pharmacol Ther. 2014 Feb;39(4):407-17. doi: 10.1111/apt.12603. Epub 2014 Jan 6.

5.

Antibody repertoire profiling using bacterial display identifies reactivity signatures of celiac disease.

Spatola BN, Murray JA, Kagnoff M, Kaukinen K, Daugherty PS.

Anal Chem. 2013 Jan 15;85(2):1215-22. doi: 10.1021/ac303201d. Epub 2012 Dec 21.

Supplemental Content

Loading ...
Support Center